
Naba Alsaha Medical Services Company
Naba Alsaha Medical Services Company (9546.SR) Cash on Hand — Cash & Short-Term Investments
Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.
9546.SR · cash on hand · updated Dec 31, 2025
Core cash position
as of Dec 31, 2025Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.
Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in SAR
Net cash vs debt
Cash vs Debt · Balance Sheet HealthNaba Alsaha Medical Services Company carries a net debt position of $103.8M. Total debt ($122.8M) exceeds cash on hand ($19.0M). Naba Alsaha Medical Services Company cash vs debt ratio: 13% cash / 87% debt.
Cash on hand history
Annual cash on hand by year
9546.SR cash & short-term investments historyHealthcare Sector Cash Reserves Comparison
About cash on hand & methodology
Naba Alsaha Medical Services Company (9546.SR) cash on hand as of December 31, 2025 is $19.0M, comprising $19.0M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Naba Alsaha Medical Services Company cash and short-term investments on the balance sheet (10-K filing). Also referred to as Naba Alsaha Medical Services Company cash reserves or cash position.
Naba Alsaha Medical Services Company annual cash on hand history shows decreased -55.6% in 2025: decreased -55.6% in 2025. Naba Alsaha Medical Services Company cash reserves in 2025 reflect the company's capital allocation strategy.
Naba Alsaha Medical Services Company carries total debt of $122.8M against cash of $19.0M, resulting in a net debt position of -$103.8M. For the full balance sheet, see the Financials → Balance Sheet tab.
Frequently asked questions
9546.SR cash on hand · 5 questionsAs of December 31, 2025, Naba Alsaha Medical Services Company (9546.SR) has $18,990,205 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $18,990,205 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $18,990,205. Data sourced from the annual 10-K filing via FMP.
▸ Source: FMP /balance-sheet-statement · US GAAP · Naba Alsaha Medical Services Company · Naba Alsaha Medical Services Company SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025